CN112834752A - Blood glucose standardized measurement system, method, terminal and medium suitable for large-batch crowd - Google Patents
Blood glucose standardized measurement system, method, terminal and medium suitable for large-batch crowd Download PDFInfo
- Publication number
- CN112834752A CN112834752A CN202110013925.XA CN202110013925A CN112834752A CN 112834752 A CN112834752 A CN 112834752A CN 202110013925 A CN202110013925 A CN 202110013925A CN 112834752 A CN112834752 A CN 112834752A
- Authority
- CN
- China
- Prior art keywords
- blood glucose
- blood sugar
- quality control
- data
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 208
- 210000004369 blood Anatomy 0.000 title claims abstract description 208
- 238000005259 measurement Methods 0.000 title claims abstract description 41
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 126
- 239000008103 glucose Substances 0.000 title claims description 126
- 238000000034 method Methods 0.000 title claims description 13
- 238000003908 quality control method Methods 0.000 claims abstract description 49
- 230000002159 abnormal effect Effects 0.000 claims abstract description 48
- 238000001514 detection method Methods 0.000 claims abstract description 36
- 238000000691 measurement method Methods 0.000 claims abstract description 12
- 238000012360 testing method Methods 0.000 claims description 48
- 238000004590 computer program Methods 0.000 claims description 10
- 238000013480 data collection Methods 0.000 claims description 5
- 230000005856 abnormality Effects 0.000 claims description 3
- 238000007689 inspection Methods 0.000 abstract description 8
- 238000012545 processing Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The application provides a blood sugar standardized measurement system, a blood sugar standardized measurement method, a blood sugar standardized measurement terminal and a blood sugar standardized measurement medium which are suitable for large-batch crowds, wherein the blood sugar standardized measurement terminal comprises a startup quality control module, a power-on quality control module and a power-on quality control module, wherein the startup quality control module is used for performing quality control after; the blood sugar data acquisition module is used for acquiring blood sugar data of the crowd in batches after the startup quality control module completes startup quality control; and the reverse checking module is used for reversely checking whether the blood sugar data acquisition module works normally or not according to the abnormal rate of the blood sugar data of the batch population. The invention carries out startup quality control before formally carrying out mass measurement, greatly improves the detection quality and realizes the standardization and the precision of blood sugar measurement. In addition, reverse inspection of the measuring instrument is performed on the basis of batch crowd detection data, which is an inspection function that a small amount of data cannot realize, and the detection quality is reversely improved.
Description
Technical Field
The present application relates to the field of standardized measurement technologies, and in particular, to a system, a method, a terminal, and a medium for standardized measurement of blood glucose suitable for mass populations.
Background
Nowadays, blood glucose measurement becomes more and more convenient, has the domestic blood glucose meter that makes things convenient for the patient to use at home, also has the medical blood glucose meter that supplies the patient to go to the hospital and carry out blood glucose measurement. However, in both household and medical glucometers, if the standard quality control and measurement are not performed according to the requirements, the measurement results are easy to deviate, the related quality control and measurement results cannot be directly stored and uploaded, and the manual reporting is time-consuming and labor-consuming; and systematic analysis can not be carried out on the deviation of the blood sugar measurement data of large-scale crowds, so that the accuracy of the blood sugar measurement data of the crowds can be reversely traced, and whether the measuring instrument, consumables and the measuring process have problems or not can be timely sensed.
Disclosure of Invention
In view of the above-mentioned shortcomings of the prior art, it is an object of the present application to provide a standardized blood glucose measurement system, method, terminal and medium suitable for large-scale population, which solve the problems of the prior art.
To achieve the above and other related objects, a first aspect of the present application provides a standardized blood glucose measurement system suitable for a large population, comprising: the startup quality control module is used for performing quality control after startup; the blood sugar data acquisition module is used for acquiring blood sugar data of the crowd in batches after the startup quality control module completes startup quality control; and the reverse checking module is used for reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel work normally or not according to the abnormal rate of the blood sugar data of the batch population.
In some embodiments of the first aspect of the present application, the power-on quality control module performs a blood glucose test on a standard sample after power-on; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some embodiments of the first aspect of the present application, the reverse test module performs reverse test according to the deviation degree of the blood glucose data of the batch population, and the reverse test item at least includes testing whether the blood glucose values are distributed in a biased state.
In some embodiments of the first aspect of the present application, the manner in which the reverse direction test module tests whether the blood glucose meter, the blood glucose strip, and the blood glucose meter are operating properly comprises: comparing the abnormal rate of the blood glucose data of the batch population under the conditions of the same operator, the same measuring equipment and different batches of test paper, and if the abnormal rate is higher than a preset threshold value, judging that the test paper is abnormal; comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same operator, the same batch of paper slips and different measuring devices, and if the abnormal rate is higher than a preset threshold value, judging that the measuring device is abnormal; comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same batch of paper slips, the same measuring equipment and different operators, and if the abnormal rate is higher than a preset threshold value, judging that the blood glucose measuring operators are abnormal in operation; and comparing the abnormal rate of the blood glucose data of the batch population under the conditions of different equipment models, and if the abnormal rate is higher than a preset threshold value, judging that the equipment of the model is abnormal.
In some embodiments of the first aspect of the present application, the startup quality control module is configured to determine whether the usage and storage of the blood glucose test strips meet requirements according to the data of the blood glucose test strips in and out of the database, so as to determine whether the blood glucose test strips are working normally.
To achieve the above and other related objects, a second aspect of the present application provides a standardized measurement method of blood glucose suitable for a large population, comprising: performing quality control after starting up; collecting blood sugar data of a batch of people after the startup quality control is finished; and reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel work normally or not according to the abnormal rate of the blood sugar data of the batch population.
In some embodiments of the second aspect of the present application, the performing quality control after booting includes: carrying out blood sugar detection on a standard sample after starting up; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some embodiments of the second aspect of the present application, the reversely checking whether the blood glucose meter, the blood glucose strip and the blood glucose measuring person operate normally according to the abnormal rate of the blood glucose data of the batch population comprises: and reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel operate normally or not according to the deviation degree of the blood sugar data of the batch population.
To achieve the above and other related objects, a third aspect of the present application provides a computer-readable storage medium having a computer program stored thereon, where the computer program is executed by a processor to implement the standardized blood glucose measurement method suitable for a large group of people.
To achieve the above and other related objects, a fourth aspect of the present application provides an electronic terminal comprising: a processor and a memory; the memory is used for storing computer programs, and the processor is used for executing the computer programs stored by the memory so as to enable the terminal to execute the blood sugar standardized measurement method suitable for large-batch crowds.
As described above, the blood glucose standardized measurement system, method, terminal and medium applicable to large-batch crowds of the application have the following beneficial effects: the invention carries out startup quality control before formally carrying out mass measurement, greatly improves the detection quality and realizes the standardization and the precision of blood sugar measurement. In addition, reverse inspection of the measuring instrument is performed on the basis of batch crowd detection data, which is an inspection function that a small amount of data cannot realize, and the detection quality is reversely improved.
Drawings
Fig. 1 is a schematic diagram of a standardized blood glucose measurement system suitable for a large population according to an embodiment of the present invention.
Fig. 2 is a flow chart of a standardized blood glucose measurement method suitable for a large population according to an embodiment of the present invention.
Fig. 3 is a schematic structural diagram of an electronic terminal according to an embodiment of the present application.
Detailed Description
The following description of the embodiments of the present application is provided by way of specific examples, and other advantages and effects of the present application will be readily apparent to those skilled in the art from the disclosure herein. The present application is capable of other and different embodiments and its several details are capable of modifications and/or changes in various respects, all without departing from the spirit of the present application. It is to be noted that the features in the following embodiments and examples may be combined with each other without conflict.
It is noted that in the following description, reference is made to the accompanying drawings which illustrate several embodiments of the present application. It is to be understood that other embodiments may be utilized and that mechanical, structural, electrical, and operational changes may be made without departing from the spirit and scope of the present application. The following detailed description is not to be taken in a limiting sense, and the scope of embodiments of the present application is defined only by the claims of the issued patent. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the application. Spatially relative terms, such as "upper," "lower," "left," "right," "lower," "below," "lower," "above," "upper," and the like, may be used herein to facilitate describing one element or feature's relationship to another element or feature as illustrated in the figures.
In this application, unless expressly stated or limited otherwise, the terms "mounted," "connected," "secured," "retained," and the like are to be construed broadly and can, for example, be fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present application can be understood by those of ordinary skill in the art as appropriate.
Also, as used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context indicates otherwise. It will be further understood that the terms "comprises," "comprising," and/or "comprising," when used in this specification, specify the presence of stated features, operations, elements, components, items, species, and/or groups, but do not preclude the presence, or addition of one or more other features, operations, elements, components, items, species, and/or groups thereof. The terms "or" and/or "as used herein are to be construed as inclusive or meaning any one or any combination. Thus, "A, B or C" or "A, B and/or C" means "any of the following: a; b; c; a and B; a and C; b and C; A. b and C ". An exception to this definition will occur only when a combination of elements, functions or operations are inherently mutually exclusive in some way.
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions in the embodiments of the present invention are further described in detail by the following embodiments in conjunction with the accompanying drawings. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Fig. 1 is a schematic diagram of a standardized blood glucose measurement system suitable for a large group of people according to an embodiment of the present invention. The standardized blood glucose measurement system 100 of the present embodiment includes a power-on quality control module 101, a blood glucose data acquisition module 102, and a reverse test module 103.
Specifically, the startup quality control module 101 is used for performing quality control after startup; the blood glucose data acquisition module 102 is used for acquiring blood glucose data of a batch of people after the startup quality control module completes startup quality control; the reverse checking module 103 is used for reversely checking whether the blood glucose data acquisition module works normally according to the abnormal rate of the blood glucose data of the batch population.
In some examples, the manner of controlling the startup quality control module 101 includes: the startup quality control module 101 performs blood glucose detection on a standard sample after startup; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
It should be noted that existing glucose meters, whether for home use or for medical use, typically start measuring upon opening, but this has the problem that reuse of the meter after it has been turned off is likely to be inaccurate. In addition, common household glucometers or medical glucometers are used for measuring single people or measuring a plurality of people but have fewer measuring times in a period of time; however, the standardized blood glucose measurement system of the present invention is for a large population (e.g., a community service organization dedicated to chronic disease detection), which puts higher demands on the measurement accuracy of the blood glucose meter, otherwise, a huge amount of data is likely to be discarded once errors occur. In view of the above, the present invention provides a solution for controlling quality immediately after power-on, wherein a blood glucose meter tests a standard sample after power-on; if the test result is consistent with the theoretical result (for example, the result values are all 9), the blood sugar data acquisition module is considered to meet the quality control requirement, otherwise, the blood sugar data acquisition module is considered to need to be continuously debugged until the blood sugar detection value of the standard sample is consistent with the theoretical value.
In some examples, the blood glucose data collection module 102 may be a blood glucose meter or other instrument capable of performing blood glucose measurements, and may be specifically selected from a photovoltaic type or an electrode type. Since the blood glucose data acquisition module 102 in this embodiment needs to perform blood glucose tests on a large number of people, the blood glucose data of the large number of people should be performed after the startup quality control is completed.
In some examples, the reverse verification module 103 is configured to perform a reverse verification of the proper operation of the blood glucose meter, the blood glucose strip, and the blood glucose meter based on the collected blood glucose data of the large group of people. Specifically, the standardized measurement of blood glucose suitable for large-scale crowds can realize the collection of batch blood glucose data in a short time, and the data can be used for analyzing the abnormal rate of the operation of a blood glucose detector, a blood glucose test paper and a blood glucose measuring person.
Further, the reverse test module 103 performs reverse test according to the deviation degree of the blood glucose data of the batch population, and the reverse test item at least comprises a test result of whether the blood glucose values are distributed in a biased state. The biased distribution refers to a distribution in which the peak of the frequency distribution is located on one side and the tail extends to the other side, and can be divided into a positive biased state and a negative biased state. For example, the degree of deviation may be expressed by a deviation factor, which is expressed by the formula:
wherein,
wherein g1 represents the number of skews; x is the value of a variable,
is the average number of samples, n is the frequency,
for merging and correcting the number, if the group distance is used in the calculation process, the number needs to be corrected, and if the original data is used for direct calculation, the number does not need to be corrected; if g1 is 0, symmetry is indicated; g1 is positive, the curve is in positive offset state, and the longer tail of the curve is at the right side; when g1 is negative, the curve is in negative state, and the longer tail of the curve is at the left side; the larger the absolute value of g1, the more the deviation.
In some examples, to further distinguish whether a blood glucose meter is abnormal, a blood glucose strip is abnormal, or an operator is operating abnormally, the present example provides the following solutions:
1) comparing the abnormal rate of the blood glucose data of the batch population under the conditions of the same operator, the same measuring equipment and different batches of test paper; and if the abnormality rate is higher than a preset threshold value, judging that the blood glucose test paper is abnormal.
2) Comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same operator, the same batch of paper strips and different measuring devices; and if the abnormal rate is higher than a preset threshold value, judging that the measuring equipment is abnormal.
3) Comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same batch of paper slips, the same measuring equipment and different operators; if the abnormality rate is higher than the preset threshold value, the test paper and the test paper are judged to be not abnormal, but the operation method of the operator is abnormal.
4) And comparing the abnormal rate of the blood glucose data of the batch population under the conditions of different equipment models, and if the abnormal rate is higher than a preset threshold value, judging that the equipment of the model is abnormal.
In some examples, the startup quality control module is configured to determine whether the usage and storage of the blood glucose test strips meet requirements according to the data of the blood glucose test strips in and out of the database, so as to determine whether the blood glucose test strips are working normally.
In some examples, after detecting the blood glucose data of a batch of people, the blood glucose standardized measurement system of the embodiment uploads the blood glucose data to the cloud server for storage, so that historical measurement data can be retrieved when the people perform the next blood glucose measurement or perform a relevant medical visit, and a function of data traceable query is realized.
Therefore, the blood sugar standardized measurement system applicable to large-batch crowds provided by the embodiment can be used for starting up quality control before formal large-batch measurement, so that the detection quality is greatly improved, and the standardization and the accuracy of blood sugar measurement are realized. In addition, reverse inspection of the measuring instrument is performed on the basis of batch crowd detection data, which is an inspection function that a small amount of data cannot realize, and the detection quality is reversely improved.
It should be understood that the division of the modules of the above apparatus is only a logical division, and the actual implementation may be wholly or partially integrated into one physical entity or may be physically separated. And these modules can be realized in the form of software called by processing element; or may be implemented entirely in hardware; and part of the modules can be realized in the form of calling software by the processing element, and part of the modules can be realized in the form of hardware. For example, the blood glucose data collection module may be a separately established processing element, or may be implemented by being integrated in a chip of the system, or may be stored in a memory of the system in the form of program codes, and a processing element of the system calls and executes the functions of the blood glucose data collection module. Other modules are implemented similarly. In addition, all or part of the modules can be integrated together or can be independently realized. The processing element described herein may be an integrated circuit having signal processing capabilities. In implementation, each step of the above method or each module above may be implemented by an integrated logic circuit of hardware in a processor element or an instruction in the form of software.
For example, the above modules may be one or more integrated circuits configured to implement the above methods, such as: one or more Application Specific Integrated Circuits (ASICs), or one or more microprocessors (DSPs), or one or more Field Programmable Gate Arrays (FPGAs), among others. For another example, when one of the above modules is implemented in the form of a Processing element scheduler code, the Processing element may be a general-purpose processor, such as a Central Processing Unit (CPU) or other processor capable of calling program code. For another example, these modules may be integrated together and implemented in the form of a system-on-a-chip (SOC).
Fig. 2 is a flow chart showing a standardized blood glucose measurement method suitable for a large population according to an embodiment of the present invention. The standardized blood glucose measurement method suitable for large-batch people mainly comprises the steps S21-S23.
Step S21: and performing quality control after starting.
Step S22: and collecting blood sugar data of the crowd in batches after the startup quality control is finished.
Step S23: and reversely checking whether the glucometer and the blood glucose test paper work normally or not according to the abnormal rate of the blood glucose data of the batch population.
In some examples, the performing quality control after booting includes: carrying out blood sugar detection on a standard sample after starting up; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
In some examples, the reverse checking whether the blood glucose meter, the blood glucose strip, and the blood glucose measuring personnel operate normally according to the abnormal rate of the blood glucose data of the batch population comprises: and reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel operate normally or not according to the deviation degree of the blood sugar data of the batch population.
It should be noted that the standardized blood glucose measurement method applicable to large-batch crowds provided by the embodiment can be applied to a blood glucose detection device with a control chip, and is not only used for collecting blood glucose data of the large-batch crowds, but also used for performing quality control after starting up, and reversely checking whether the blood glucose detector, the blood glucose test paper and the blood glucose measurement personnel work normally or not according to the abnormal rate of the blood glucose data of the large-batch crowds. The control chip includes, but is not limited to, an arm (advanced RISC machines) control chip, an fpga (field Programmable Gate array) control chip, an soc (system on chip) control chip, a dsp (digital Signal processing) control chip, or an mcu (micro controller unit) control chip.
Fig. 3 is a schematic structural diagram of an electronic terminal according to an embodiment of the present invention. The embodiment of the application provides a schematic structural diagram of an electronic terminal. This example provides an electronic terminal, includes: a processor 31, a memory 32, a communicator 33; the memory 32 is connected with the processor 31 and the communicator 33 through a system bus and is used for mutual communication, the memory 32 is used for storing computer programs, the communicator 33 is used for communicating with other devices, and the processor 31 is used for running the computer programs, so that the electronic terminal executes the steps of the blood sugar standardized measurement method suitable for the large-batch crowd.
The above-mentioned system bus may be a Peripheral Component Interconnect (PCI) bus, an Extended Industry Standard Architecture (EISA) bus, or the like. The system bus may be divided into an address bus, a data bus, a control bus, and the like. For ease of illustration, only one thick line is shown, but this does not mean that there is only one bus or one type of bus. The communication interface is used for realizing communication between the database access device and other equipment (such as a client, a read-write library and a read-only library). The Memory may include a Random Access Memory (RAM), and may further include a non-volatile Memory (non-volatile Memory), such as at least one disk Memory.
The Processor may be a general-purpose Processor, and includes a Central Processing Unit (CPU), a Network Processor (NP), and the like; the Integrated Circuit may also be a Digital Signal Processor (DSP), an Application Specific Integrated Circuit (ASIC), a Field Programmable Gate Array (FPGA) or other Programmable logic device, a discrete Gate or transistor logic device, or a discrete hardware component.
The invention also provides a computer-readable storage medium, on which a computer program is stored, which, when being executed by a processor, carries out the standardized method for measuring blood glucose, which is suitable for a large group of people.
Those of ordinary skill in the art will understand that: in the embodiments provided herein, the computer-readable and writable storage medium may include read-only memory, random-access memory, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, flash memory, a USB flash drive, a removable hard disk, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer. Also, any connection is properly termed a computer-readable medium. For example, if the instructions are transmitted from a website, server, or other remote source using a coaxial cable, fiber optic cable, twisted pair, Digital Subscriber Line (DSL), or wireless technologies such as infrared, radio, and microwave, then the coaxial cable, fiber optic cable, twisted pair, DSL, or wireless technologies such as infrared, radio, and microwave are included in the definition of medium. It should be understood, however, that computer-readable-writable storage media and data storage media do not include connections, carrier waves, signals, or other transitory media, but are intended to be non-transitory, tangible storage media. Disk and disc, as used in this application, includes Compact Disc (CD), laser disc, optical disc, Digital Versatile Disc (DVD), floppy disk and blu-ray disc where disks usually reproduce data magnetically, while discs reproduce data optically with lasers.
In summary, the present invention provides a system, a method, a terminal and a medium for standardized measurement of blood glucose suitable for mass population. In addition, reverse inspection of measuring instruments and consumables is performed on the basis of batch crowd detection data, which is an inspection function that a small amount of data cannot realize, and detection quality is reversely promoted. Therefore, the application effectively overcomes various defects in the prior art and has high industrial utilization value.
The above embodiments are merely illustrative of the principles and utilities of the present application and are not intended to limit the application. Any person skilled in the art can modify or change the above-described embodiments without departing from the spirit and scope of the present application. Accordingly, it is intended that all equivalent modifications or changes which can be made by those skilled in the art without departing from the spirit and technical concepts disclosed in the present application shall be covered by the claims of the present application.
Claims (10)
1. A standardized blood glucose measurement system suitable for a large population of people, comprising:
the startup quality control module is used for performing quality control after startup;
the blood glucose data acquisition module is used for acquiring blood glucose data of a batch of people by using a blood glucose meter after the startup quality control module completes startup quality control;
and the reverse checking module is used for reversely checking whether the blood glucose data acquisition module works normally or not according to the abnormal rate of the blood glucose data of the batch population, and at least comprises a reverse checking blood glucose tester, blood glucose test paper and a blood glucose measurer which operate normally or not.
2. The system of claim 1, wherein the power-on quality control module performs a blood glucose test on a standard sample after power-on; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
3. The system of claim 1, wherein the reverse test module performs a reverse test to determine whether the blood glucose data collection module is normal according to the deviation degree of the blood glucose data of the batch population, and the reverse test item at least comprises a test to determine whether the blood glucose values are distributed in a biased manner.
4. The standardized blood glucose measurement system of claim 1 wherein the manner in which the reverse test module verifies that the blood glucose data collection module is functioning properly comprises:
comparing the abnormal rate of the blood glucose data of the batch population under the conditions of the same operator, the same measuring equipment and different batches of test paper; if the abnormality rate is higher than a preset threshold value, judging that the blood glucose test paper is abnormal;
comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same operator, the same batch of paper strips and different measuring devices; if the abnormal rate is higher than a preset threshold value, judging that the measuring equipment is abnormal;
comparing the abnormal rate of the blood glucose data of the crowd in batches under the conditions of the same batch of paper slips, the same measuring equipment and different operators; if the abnormal rate is higher than a preset threshold value, judging that the operation of the blood sugar measuring personnel is abnormal;
comparing the abnormal rate of the blood glucose data of the batch population under the conditions of different equipment models; and if the abnormal rate is higher than a preset threshold value, judging that the equipment of the model is abnormal.
5. The system of claim 1, wherein the power-on quality control module is configured to determine whether the blood glucose test strips are used and stored according to the data of the blood glucose test strips in and out of the database, so as to determine whether the blood glucose test strips are working normally.
6. A standardized blood glucose measurement method suitable for a large-batch population is characterized by comprising the following steps:
performing quality control after starting up;
collecting blood sugar data of a batch of people after the startup quality control is finished;
and reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel work normally or not according to the abnormal rate of the blood sugar data of the batch population.
7. The method for standardized measurement of blood glucose as set forth in claim 6, wherein the controlling after the power-on comprises: carrying out blood sugar detection on a standard sample after starting up; if the blood sugar detection value of the standard sample is consistent with the theoretical value, determining that the blood sugar data acquisition module meets the quality control requirement; and if the blood sugar detection value does not accord with the theoretical value, debugging the blood sugar data acquisition module until the blood sugar detection value of the standard sample accords with the theoretical value.
8. The standardized blood glucose measurement method of claim 6, wherein the back checking whether the blood glucose meter, the blood glucose strip and the blood glucose measuring personnel operate normally according to the abnormal rate of the blood glucose data of the batch population comprises: and reversely checking whether the blood sugar detector, the blood sugar test paper and the blood sugar measuring personnel operate normally or not according to the deviation degree of the blood sugar data of the batch population.
9. A computer-readable storage medium, on which a computer program is stored, which, when being executed by a processor, carries out a standardized measurement of blood glucose as claimed in any one of claims 6 to 8, which is suitable for a large group of people.
10. An electronic terminal, comprising: a processor and a memory;
the memory is used for storing a computer program;
the processor is configured to execute the computer program stored in the memory to cause the terminal to perform the standardized blood glucose measurement method according to any one of claims 6 to 8, which is suitable for a large group of people.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110013925.XA CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110013925.XA CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112834752A true CN112834752A (en) | 2021-05-25 |
| CN112834752B CN112834752B (en) | 2024-04-30 |
Family
ID=75926292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110013925.XA Active CN112834752B (en) | 2021-01-05 | 2021-01-05 | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112834752B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116990532A (en) * | 2023-09-25 | 2023-11-03 | 北京华益精点生物技术有限公司 | Quality control method and related equipment |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101067833A (en) * | 2007-05-09 | 2007-11-07 | 冯连元 | Method for unified standardizing various examination and test results normal range referencel value and its actual measured value in clinical medicine |
| CN101872182A (en) * | 2010-05-21 | 2010-10-27 | 杭州电子科技大学 | Batch process monitoring method based on recursive non-linear partial least square |
| US20120179017A1 (en) * | 2009-09-17 | 2012-07-12 | Terumo Kabushiki Kaisha | Blood glucose meter and blood glucose level measurement method |
| CN106535760A (en) * | 2014-06-16 | 2017-03-22 | 迪亚蒙泰克有限公司 | Non-invasive substance analysis |
| JP2018025517A (en) * | 2016-08-12 | 2018-02-15 | セイコーエプソン株式会社 | Information output system, information output method, and information output program |
| CN108196058A (en) * | 2018-01-02 | 2018-06-22 | 深圳市双平泰医疗科技有限公司 | Blood glucose meter Quality Control detection method and system |
| CN110007087A (en) * | 2019-04-12 | 2019-07-12 | 三诺生物传感股份有限公司 | A kind of measurement blood glucose method based on chargeable blood glucose meter |
| CN110097962A (en) * | 2019-05-07 | 2019-08-06 | 北京医院 | Glycosylated hemoglobin detection and evaluation criterion system |
| CN110124150A (en) * | 2019-04-30 | 2019-08-16 | 广东食品药品职业学院 | It is a kind of based on adaptive softening because of the generalized predictive control closed-loop insulin infusion system of substrategy |
| CN110689954A (en) * | 2019-10-10 | 2020-01-14 | 王月娥 | Multifunctional endocrine detector control system and control method |
| CN110927654A (en) * | 2019-08-23 | 2020-03-27 | 国网天津市电力公司电力科学研究院 | Batch running state evaluation method for intelligent electric energy meters |
| CN111307889A (en) * | 2020-04-14 | 2020-06-19 | 漳州卫生职业学院 | High-precision blood glucose detection device |
-
2021
- 2021-01-05 CN CN202110013925.XA patent/CN112834752B/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101067833A (en) * | 2007-05-09 | 2007-11-07 | 冯连元 | Method for unified standardizing various examination and test results normal range referencel value and its actual measured value in clinical medicine |
| US20120179017A1 (en) * | 2009-09-17 | 2012-07-12 | Terumo Kabushiki Kaisha | Blood glucose meter and blood glucose level measurement method |
| CN101872182A (en) * | 2010-05-21 | 2010-10-27 | 杭州电子科技大学 | Batch process monitoring method based on recursive non-linear partial least square |
| CN106535760A (en) * | 2014-06-16 | 2017-03-22 | 迪亚蒙泰克有限公司 | Non-invasive substance analysis |
| JP2018025517A (en) * | 2016-08-12 | 2018-02-15 | セイコーエプソン株式会社 | Information output system, information output method, and information output program |
| CN108196058A (en) * | 2018-01-02 | 2018-06-22 | 深圳市双平泰医疗科技有限公司 | Blood glucose meter Quality Control detection method and system |
| CN110007087A (en) * | 2019-04-12 | 2019-07-12 | 三诺生物传感股份有限公司 | A kind of measurement blood glucose method based on chargeable blood glucose meter |
| CN110124150A (en) * | 2019-04-30 | 2019-08-16 | 广东食品药品职业学院 | It is a kind of based on adaptive softening because of the generalized predictive control closed-loop insulin infusion system of substrategy |
| CN110097962A (en) * | 2019-05-07 | 2019-08-06 | 北京医院 | Glycosylated hemoglobin detection and evaluation criterion system |
| CN110927654A (en) * | 2019-08-23 | 2020-03-27 | 国网天津市电力公司电力科学研究院 | Batch running state evaluation method for intelligent electric energy meters |
| CN110689954A (en) * | 2019-10-10 | 2020-01-14 | 王月娥 | Multifunctional endocrine detector control system and control method |
| CN111307889A (en) * | 2020-04-14 | 2020-06-19 | 漳州卫生职业学院 | High-precision blood glucose detection device |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116990532A (en) * | 2023-09-25 | 2023-11-03 | 北京华益精点生物技术有限公司 | Quality control method and related equipment |
| CN116990532B (en) * | 2023-09-25 | 2023-12-05 | 北京华益精点生物技术有限公司 | Quality control method and related equipment |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112834752B (en) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015009354A1 (en) | Methods and systems for processing test results based on patient-specific data and reference data | |
| CN117152152B (en) | Production management system and method for detection kit | |
| JP6060209B2 (en) | System and method for obtaining statistically effective analytical mean and analytical range of quality control substances | |
| CN117630800A (en) | Fault diagnosis method and system for automatic calibrating device of electric energy meter | |
| CN112834752B (en) | Blood glucose standardized measurement system, method, terminal and medium suitable for large-scale crowd | |
| CN109872813A (en) | Detection system positive rate appraisal procedure and device, computer readable storage medium | |
| CN110580220B (en) | Method for measuring code segment execution time and terminal equipment | |
| CN115268988A (en) | Blood coagulation item detection method and device | |
| CN103336739B (en) | Method for testing software and platform | |
| CN103743878A (en) | Water quality monitoring data processing method and device | |
| CN116559929B (en) | Super-computing platform-based radiation detector characterization method and device | |
| CN118150833A (en) | Blood glucose meter quality inspection method and device, electronic equipment and medium | |
| CN115575785A (en) | IGBT thermal resistance test system | |
| CN115290165A (en) | Detection method, system and device of ultrasonic water meter | |
| CN114117831A (en) | Method and device for analyzing data of meter with measuring value in intelligent laboratory | |
| CN116183010B (en) | Fault diagnosis method, device and equipment for dynamic weighing sensor and storage medium | |
| CN111128360B (en) | Method, device and system for automatically checking medical equipment inspection parameters | |
| CN112762976B (en) | Automatic method and device for comprehensive test of BMC (baseboard management controller) sensor | |
| CN118583906B (en) | X-ray spectrum detection system, method, equipment and storage medium | |
| CN117373586B (en) | Blood glucose data comparison method and related equipment | |
| CN118914848A (en) | Test method, system and storage medium for battery pack quality detection | |
| CN117951529B (en) | Sample acquisition method, device and equipment for hard disk data fault prediction | |
| CN118012780A (en) | Stability testing method, device, equipment and medium for intelligent moving mirror | |
| JP2009134518A (en) | Verification method for test program, and verification system therefor | |
| CN118335175A (en) | Automatic hard disk testing method, system, equipment and storage medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |